These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 9335087)

  • 1. Frontal 5-HT2A receptors studied in depressive patients during chronic treatment by selective serotonin reuptake inhibitors.
    Massou JM; Trichard C; Attar-Levy D; Feline A; Corruble E; Beaufils B; Martinot JL
    Psychopharmacology (Berl); 1997 Sep; 133(1):99-101. PubMed ID: 9335087
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effect of paroxetine on 5-HT(2A) receptors in depression: an [(18)F]setoperone PET imaging study.
    Meyer JH; Kapur S; Eisfeld B; Brown GM; Houle S; DaSilva J; Wilson AA; Rafi-Tari S; Mayberg HS; Kennedy SH
    Am J Psychiatry; 2001 Jan; 158(1):78-85. PubMed ID: 11136637
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Decrease in brain serotonin 2 receptor binding in patients with major depression following desipramine treatment: a positron emission tomography study with fluorine-18-labeled setoperone.
    Yatham LN; Liddle PF; Dennie J; Shiah IS; Adam MJ; Lane CJ; Lam RW; Ruth TJ
    Arch Gen Psychiatry; 1999 Aug; 56(8):705-11. PubMed ID: 10435604
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The cortical serotonin2 receptors studied with positron-emission tomography and [18F]-setoperone during depressive illness and antidepressant treatment with clomipramine.
    Attar-Lévy D; Martinot JL; Blin J; Dao-Castellana MH; Crouzel C; Mazoyer B; Poirier MF; Bourdel MC; Aymard N; Syrota A; Féline A
    Biol Psychiatry; 1999 Jan; 45(2):180-6. PubMed ID: 9951565
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Brain serotonin1A receptor binding measured by positron emission tomography with [11C]WAY-100635: effects of depression and antidepressant treatment.
    Sargent PA; Kjaer KH; Bench CJ; Rabiner EA; Messa C; Meyer J; Gunn RN; Grasby PM; Cowen PJ
    Arch Gen Psychiatry; 2000 Feb; 57(2):174-80. PubMed ID: 10665620
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effects of single dose nefazodone and paroxetine upon 5-HT2A binding potential in humans using [18F]-setoperone PET.
    Meyer JH; Cho R; Kennedy S; Kapur S
    Psychopharmacology (Berl); 1999 Jun; 144(3):279-81. PubMed ID: 10435395
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Decreased serotonin 2A receptor densities in neuroleptic-naive patients with schizophrenia: A PET study using [(18)F]setoperone.
    Ngan ET; Yatham LN; Ruth TJ; Liddle PF
    Am J Psychiatry; 2000 Jun; 157(6):1016-8. PubMed ID: 10831488
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Brain serotonin2 receptors in major depression: a positron emission tomography study.
    Yatham LN; Liddle PF; Shiah IS; Scarrow G; Lam RW; Adam MJ; Zis AP; Ruth TJ
    Arch Gen Psychiatry; 2000 Sep; 57(9):850-8. PubMed ID: 10986548
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A method for the in vivo investigation of the serotonergic 5-HT2 receptors in the human cerebral cortex using positron emission tomography and 18F-labeled setoperone.
    Blin J; Sette G; Fiorelli M; Bletry O; Elghozi JL; Crouzel C; Baron JC
    J Neurochem; 1990 May; 54(5):1744-54. PubMed ID: 2182776
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Binding of antipsychotic drugs to cortical 5-HT2A receptors: a PET study of chlorpromazine, clozapine, and amisulpride in schizophrenic patients.
    Trichard C; Paillère-Martinot ML; Attar-Levy D; Recassens C; Monnet F; Martinot JL
    Am J Psychiatry; 1998 Apr; 155(4):505-8. PubMed ID: 9545996
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Platelet serotonergic indices in major depression: up-regulation of 5-HT2A receptors unchanged by antidepressant treatment.
    Hrdina PD; Bakish D; Ravindran A; Chudzik J; Cavazzoni P; Lapierre YD
    Psychiatry Res; 1997 Feb; 66(2-3):73-85. PubMed ID: 9075272
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genetic dysfunction of serotonin 2A receptor hampers response to antidepressant drugs: A translational approach.
    Qesseveur G; Petit AC; Nguyen HT; Dahan L; Colle R; Rotenberg S; Seif I; Robert P; David D; Guilloux JP; Gardier AM; Verstuyft C; Becquemont L; Corruble E; Guiard BP
    Neuropharmacology; 2016 Jun; 105():142-153. PubMed ID: 26764241
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 5-HT(2A) receptor binding is reduced in drug-naive and unchanged in SSRI-responder depressed patients compared to healthy controls: a PET study.
    Messa C; Colombo C; Moresco RM; Gobbo C; Galli L; Lucignani G; Gilardi MC; Rizzo G; Smeraldi E; Zanardi R; Artigas F; Fazio F
    Psychopharmacology (Berl); 2003 Apr; 167(1):72-8. PubMed ID: 12632246
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 5-HT2A gene variants influence specific and different aspects of antidepressant response in Japanese and Italian mood disorder patients.
    Kato M; Zanardi R; Rossini D; De Ronchi D; Okugawa G; Kinoshita T; Colombo C; Serretti A
    Psychiatry Res; 2009 May; 167(1-2):97-105. PubMed ID: 19361869
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 5-HT(1A) receptor binding changes in patients with major depressive disorder before and after antidepressant treatment: a pilot [¹⁸F]MPPF positron emission tomography study.
    Lothe A; Saoud M; Bouvard S; Redouté J; Lerond J; Ryvlin P
    Psychiatry Res; 2012 Jul; 203(1):103-4. PubMed ID: 22863653
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Decreased frontal serotonin 5-HT 2a receptor binding index in deliberate self-harm patients.
    Audenaert K; Van Laere K; Dumont F; Slegers G; Mertens J; van Heeringen C; Dierckx RA
    Eur J Nucl Med; 2001 Feb; 28(2):175-82. PubMed ID: 11303887
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Imaging the serotonergic system in depression.
    Dhaenen H
    Eur Arch Psychiatry Clin Neurosci; 2001; 251 Suppl 2():II76-80. PubMed ID: 11824843
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The pharmacological basis of the serotonin system: Application to antidepressant response].
    David DJ; Gardier AM
    Encephale; 2016 Jun; 42(3):255-63. PubMed ID: 27112704
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Efficacy of atypical antipsychotics in depressive syndromes].
    Quintin P; Thomas P
    Encephale; 2004; 30(6):583-9. PubMed ID: 15738862
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical implication of microdialysis findings.
    Deakin JF; Graeff FG; Guimaraes FS
    Trends Pharmacol Sci; 1993 Jul; 14(7):263. PubMed ID: 8129813
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.